openPR Logo
Press release

Datavault AI (NASDAQ: DVLT) Licenses Healthcare IP to Wellgistics Health (NASDAQ: WGRX); Bonus Stocks in the News This Week TOON, NDRA, PRSO, RDZN more inside

11-26-2025 06:28 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Datavault AI (NASDAQ: DVLT) Licenses Healthcare IP

Datavault AI Inc. (NASDAQ: DVLT), a leader in AI-powered data experience, valuation, and monetization, today announced an exclusive licensing agreement with Wellgistics Health Inc. (NASDAQ: WGRX) for the integration of Datavault's proprietary blockchain-enabled smart-contract patent portfolio. The strategic deal positions Wellgistics to emerge as a Web 3.0 health-information transfer leader across the $634 billion U.S. prescription drug market.

The licensed technology will anchor Wellgistics' PharmacyChain Trademark smart-contract distribution infrastructure and its next-generation EinsteinRx Trademark AI hub, designed to automate prescription fulfillment workflows for manufacturers, pharmacies, physicians, patients, and payers. By enabling secure, real-time data authentication and digital-ledger transparency, the system aims to eliminate inefficiencies throughout the pharmaceutical supply chain.

Datavault's intellectual property creates a high barrier to entry for competitors across the broader $4.9 trillion U.S. healthcare ecosystem, where smart contracts stand to transform medical data exchange, formulary authorization, medication tracking, and payer coordination. With healthcare shifting toward digital-first and preventive care solutions, PwC estimates a $1 trillion opportunity to modernize provider workflows, reduce administrative burden, and drive patient-centric efficiencies.

Wellgistics Health, based in Tampa, is a hybrid physical and technology-driven healthcare IT company specializing in the movement of prescription drugs from manufacturer to patient. Its PharmacyChain initiative seeks to digitize every step of the prescription lifecycle-including electronic medical records, diagnostics, and treatment recommendations-ensuring precision, safety, and timely delivery.

Active Stocks in the News This Week

Active stocks attracting significant intraday trading attention this week include: Kartoon Studios, Inc. (NYSE: TOON), ENDRA Life Sciences (NASDAQ: NDRA), Peraso Inc. (NASDAQ: PRSO), Power Metallic (TSX-V: PNPN / OTCQB: PNPNF), Roadzen Inc. (NASDAQ: RDZN), Synergy 'Focusfactor' Corp. (NASDAQ: SNYR) and TOMI Environmental (NASDAQ: TOMZ)These names have shown elevated volume, technical momentum, or news-driven catalysts, making them notable tickers to monitor alongside DVLT's developments.

With this exclusive agreement, Datavault AI (DVLT) further establishes itself as a foundational technology provider enabling Web 3.0 transformation across healthcare infrastructure, while Wellgistics Health (WGRX) accelerates its mission to construct a fully digitized, AI-enhanced pharmaceutical distribution ecosystem.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=datavault-ai-nasdaq-dvlt-licenses-healthcare-ip-to-wellgistics-health-nasdaq-wgrx-bonus-stocks-in-the-news-this-week-toon-ndra-prso-rdzn-more-inside]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Datavault AI (NASDAQ: DVLT) Licenses Healthcare IP to Wellgistics Health (NASDAQ: WGRX); Bonus Stocks in the News This Week TOON, NDRA, PRSO, RDZN more inside here

News-ID: 4290119 • Views:

More Releases from ABNewswire

Ophthalmoscopes Market to Reach USD 294.90 Million by 2034, Growing at 5.24% CAGR | Rising Demand for Digital and Direct Ophthalmoscopes Drives Global Expansion, analyses DelveInsight
Ophthalmoscopes Market to Reach USD 294.90 Million by 2034, Growing at 5.24% CAG …
Leading ophthalmoscopes companies in the market include Baxter, HEINE Optotechnik GmbH & CO. KG, Keeler, US Ophthalmic, Rudolf Riester GmbH, Opticlar, Zumax Medical Co., Ltd., Girodmedical, Adam Rouilly Ltd., Timesco Healthcare Ltd., Zhejiang Honsun Medical Technology Co., Ltd., Iridex Corporation, NIDEK CO., Ltd., OSCAR BOSCAROL S.r.l, American Diagnostic Corporation, Lumenis Be Ltd., Veatch Ophthalmic Instruments, KIRCHNER &WILHELM GmbH + Co. KG, oDocs Eye care, Revenio Group, and others. The global ophthalmoscopes
RINVOQ Market Growth Accelerates Across IBD, Dermatology, and Rheumatology as Global Sales Momentum Strengthens | DelveInsight
RINVOQ Market Growth Accelerates Across IBD, Dermatology, and Rheumatology as Gl …
The global immunology market is witnessing a significant transformation as RINVOQ (upadacitinib) continues to demonstrate strong prescription growth, expanding indications, and robust revenue performance. DelveInsight's "RINVOQ Sales Forecast, and Market Size Analysis - 2034" report provides comprehensive insights of RINVOQ for approved indications like Ankylosing Spondylitis, Atopic Dermatitis, Axial SpA, Crohn's Disease, Giant Cell Arteritis, Psoriatic Arthritis, Rheumatoid Arthritis, and Ulcerative Colitis; as well as potential indications like Alopecia Areata, Hidradenitis
Prostate Cancer Competitive Landscape Analysis 2026: Clinical Trial Trends, Novel Therapies, Regulatory Milestones, and Future Outlook | DelveInsight
Prostate Cancer Competitive Landscape Analysis 2026: Clinical Trial Trends, Nove …
Leading Prostate Cancer companies include Merck & Co., Inc., Telix Pharmaceuticals Limited, Exelixis, Inc., AstraZeneca PLC, Pfizer Inc., Bristol-Myers Squibb Company, AbbVie Inc., BeiGene, Ltd., and Ipsen S.A., among many others-are actively developing next-generation therapies to reshape the treatment landscape. The treatment paradigm for prostate cancer is witnessing rapid transformation, with more than 150 companies advancing innovative drug candidates across diverse clinical phases. Recent milestones include multiple FDA fast-track designations, companion
Electrosurgical Devices Market to Reach USD 10,220.04 Million by 2034, Growing at 6.34% CAGR | DelveInsight
Electrosurgical Devices Market to Reach USD 10,220.04 Million by 2034, Growing a …
Electrosurgical Devices Companies in the market include B. Braun Melsungen AG, ConMed Corporation, Olympus Corporation, Apyx Medical Corporation, Medtronic, Johnson & Johnson, Smith & Nephew Plc, Erbe Elektromedizin GmbH, KLS Martin Group, BOWA-electronic GmbH & Co. KG, Modern Medical, Kirwan Surgical Products, LLC, Utah Medical Products, Inc., Hangzhou AGS MedTech Co., Ltd., New Deantronics Taiwan Ltd., Parkell, Inc., Surgical Holdings, CIMPAX, Boston Scientific Corporation, and Others The global electrosurgical devices market

All 5 Releases


More Releases for NASDAQ:

Blasting Off with Space Sector Companies Including: Ascent Solar Technologies: N …
With the Artemis II Manned Moon Mission Set to Launch Could $ASTI be on the Same Rocket Ride Trajectory as $ASTS and $LUNR? Image: https://www.globalnewslines.com/uploads/2026/02/13b5a8ac7a0c22438ac498119e1b3551.jpg $ASTI is Positioned to Serve the $1 Trillion Global Space Economy Projected by 2040 . Ascent Solar Technologies, Inc. (NASDAQ: ASTI) is backed by 40 years of R&D, 15 years of manufacturing experience, numerous awards, and a comprehensive IP and patent portfolio. ASTI is a leading provider of
Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Val …
Peraso Inc. (NASDAQ: PRSO), a leading innovator in mmWave wireless solutions, has officially acknowledged receipt of an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc. (NASDAQ: MOBX). The offer proposes a stock-for-stock exchange that values Peraso at approximately $1.20 per share, representing a 20% premium over its 30-day average closing price. However, Peraso is contesting several key points made in Mobix's June 26 press release. Financials Mischaracterized, Says Peraso Peraso rebuffed Mobix's
ZenaTech's (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
On October 1, ZenaTech (Nasdaq: ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and enterprise SaaS (software-as-a-service) applications. As businesses increasingly seek innovative ways to streamline operations and boost productivity, ZenaTech stands ready to meet these demands with its advanced AI drone solutions and comprehensive software applications. Under the leadership of CEO Dr. Shaun Passley, ZenaTech aims to leverage its
Investors Alert: EMCORE (NASDAQ: EMKR), AGBA Group (NASDAQ: AGBA), Peraso Inc. ( …
EMCORE Corporation (NASDAQ: EMKR) saw its shares soar today following a major announcement from Mobix Labs (NASDAQ: MOBX). Mobix Labs, a leader in advanced wireless solutions for military and defense, has submitted a proposal to acquire all outstanding shares of EMCORE for $3.80 per share in cash, positioning itself as a key player in the aerospace and defense sectors. This move could provide immediate value to shareholders, making it an
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO) …
Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQ: PRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands (NASDAQ: KAVL) saw its stock surge in early trading today on merger announcement. Other stocks to watch include Banzai International Inc. (NASDAQ: BNZI), which saw a 97.51% rally after
Lawsuit filed for Investors who lost money with Alphabet Inc. (NASDAQ: GOOG, NAS …
An investor, who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), filed a lawsuit over alleged violations of Federal Securities Laws by Alphabet Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NASDAQ: GOOG, NASDAQ: GOOGL investors should contact the Shareholders